Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-014083
Filing Date
2025-05-01
Accepted
2025-05-01 16:01:48
Documents
51
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20250331_10q.htm   iXBRL 10-Q 515274
2 EXHIBIT 31.1 ex_806413.htm EX-31.1 11283
3 EXHIBIT 31.2 ex_806414.htm EX-31.2 11510
4 EXHIBIT 32.1 ex_806415.htm EX-32.1 3821
5 EXHIBIT 32.2 ex_806416.htm EX-32.2 3492
  Complete submission text file 0001437749-25-014083.txt   2908808

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA govx-20250331.xsd EX-101.SCH 32161
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20250331_def.xml EX-101.DEF 199587
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20250331_lab.xml EX-101.LAB 176763
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20250331_pre.xml EX-101.PRE 221694
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20250331_cal.xml EX-101.CAL 23852
54 EXTRACTED XBRL INSTANCE DOCUMENT govx20250331_10q_htm.xml XML 318404
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 25902861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)